Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rapamycin crossover study in children with tuberous sclerosis complex and intractable epilepsy
NL-OMON36614Phase 2Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus in epilepsy, tuberous sclerosis complex (TSC), sponsored by Erasmus MC. Started Sep 2011; status: active, not recruiting.
02
Drugs
sirolimus
03
Conditions
epilepsytuberous sclerosis complex (TSC)
Beyond the preview
Go deeper on NL-OMON36614.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36614.